Mahmood A, Qureshi N H, Malik G M
Department of Neurological Surgery, Henry Ford Hospital, Detroit, MI.
Acta Neurochir (Wien). 1994;126(2-4):53-8. doi: 10.1007/BF01476410.
Recurrence of intracranial meningiomas after surgery has long been recognized, but there is still no consensus about factors responsible for recurrence. To better understand such factors, we analysed data on 276 patients with meningiomas who were treated at our institution from 1976 to 1990 (mean follow-up = 5.1 years). Effects of sex, tumour histology, tumour site, and radiotherapy on recurrence were closely studied. Using World Health Organization criteria to define malignancy, 254 of the tumours were benign and 22 were atypical or malignant. For data analysis, distinction was made between "recurrence"(i.e., reappearance of tumour after total resection) and "regrowth" (i.e., tumour enlargement after subtotal removal). Recurrence was seen in 2 of 183 benign meningiomas and in 10 of 16 malignant meningiomas. Recurrence and regrowth rates for malignant meningiomas far exceeded those for benign meningiomas (p = 0.001). Neither sex nor tumour site was associated with subsequent recurrences in patients whose tumours had been completely resected. The influence of radiotherapy was studied in terms of its effects on benign versus malignant meningiomas, whether given after complete or incomplete resection, and whether given after primary resection or on reoperation. We found that radiotherapy did not decrease "recurrence" or "regrowth" regardless of when administered, either at first resection or on recurrence. This was true for benign as well as malignant meningiomas. However, due to the small number in our series, we cannot conclude that radiotherapy has no beneficial role in the treatment of meningiomas.(ABSTRACT TRUNCATED AT 250 WORDS)
颅内脑膜瘤术后复发早已为人所知,但对于复发的相关因素仍未达成共识。为了更好地了解这些因素,我们分析了1976年至1990年在我院接受治疗的276例脑膜瘤患者的数据(平均随访时间=5.1年)。对性别、肿瘤组织学、肿瘤部位和放疗对复发的影响进行了深入研究。采用世界卫生组织的标准定义恶性肿瘤,其中254例肿瘤为良性,22例为非典型或恶性。在数据分析中,区分了“复发”(即全切术后肿瘤再次出现)和“再生长”(即次全切术后肿瘤增大)。183例良性脑膜瘤中有2例复发,16例恶性脑膜瘤中有10例复发。恶性脑膜瘤的复发率和再生长率远高于良性脑膜瘤(p=0.001)。对于肿瘤已完全切除的患者,性别和肿瘤部位均与随后的复发无关。研究了放疗对良性和恶性脑膜瘤的影响,无论是在全切还是次全切术后给予,以及是在初次切除后还是再次手术时给予。我们发现,无论放疗是在首次切除时还是复发时给予,无论对于良性还是恶性脑膜瘤,均不能降低“复发”或“再生长”。然而,由于我们研究系列中的病例数较少,我们不能得出放疗在脑膜瘤治疗中没有有益作用的结论。(摘要截选至250字)